citalopram has been researched along with apomorphine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (30.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhattacharya, SK; Datla, KP; Mitra, SK | 1 |
| Nowak, G; Pawłowski, L | 1 |
| Mazela, H; Pawłowski, L | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 2 |
| Arnt, J; Hyttel, J; Olsen, R; Overø, KF | 1 |
| Holmgren, B; Urbá-Holmgren, R | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Allikmets, L; Matto, V; Skrebuhhova, T | 2 |
| Allikmets, L; Matto, V; Pruus, K; Rudissaar, R; Skrebuhhova, T | 1 |
| Kovar, KA; Lebsanft, HB; Mayerhofer, A; Schmidt, WJ | 1 |
| Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M | 1 |
| Farhan, M; Parveen, M | 1 |
| Botha, TL; Brand, SJ; de Brouwer, G; Finger-Baier, K; van Staden, C; Wolmarans, D | 1 |
1 review(s) available for citalopram and apomorphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for citalopram and apomorphine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Serotonergic modulation of footshock induced aggression in paired rats.
Topics: 5-Hydroxytryptophan; Aggression; Agonistic Behavior; Animals; Apomorphine; Citalopram; Clorgyline; Drug Interactions; Electroshock; Female; Fenclonine; Fluoxetine; Foot; Ketanserin; Male; Metergoline; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1991 |
Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Topics: Animals; Apomorphine; Body Temperature; Brain; Citalopram; Desipramine; Male; Maprotiline; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Piperidines; Propylamines; Reserpine; Serotonin Antagonists; Thyrotropin-Releasing Hormone; Tyramine | 1987 |
Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Citalopram; Male; Mice; Norepinephrine; Propylamines; Reserpine; Thyrotropin-Releasing Hormone; Zimeldine | 1984 |
Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine.
Topics: Amitriptyline; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Citalopram; Drug Synergism; Imipramine; Male; Mianserin; Propylamines; Rats; Rats, Inbred Strains; Zimeldine | 1984 |
Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Brain Chemistry; Citalopram; Dextroamphetamine; Humans; Male; Motor Activity; Propylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Time Factors | 1984 |
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Topics: Animals; Apomorphine; Body Temperature; Citalopram; Desipramine; Fluoxetine; Male; Maprotiline; Mice; Norepinephrine; Propylamines; Reserpine; Serotonin Antagonists | 1983 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Apomorphine-induced aggressiveness and [3H]citalopram binding after antidepressant treatment in rats.
Topics: Aggression; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Binding Sites; Buspirone; Citalopram; Dopamine Agonists; Male; Posture; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms.
Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Citalopram; Desipramine; Dopamine Agents; Electroshock; Fluoxetine; Levodopa; Male; Pain Measurement; Rats; Rats, Wistar; Tryptophan | 1998 |
Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats.
Topics: Aggression; Animals; Apomorphine; Behavior, Animal; Benzylamines; Biguanides; Citalopram; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Sympathomimetics; Time Factors; Tropanes | 1999 |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram; Dopamine; Fenclonine; Functional Laterality; Hallucinogens; Male; Medial Forebrain Bundle; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2003 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2012 |
Depletion of apomorphine induced behavioral sensitization in rats treated with escitalopram.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Central Nervous System Sensitization; Citalopram; Exploratory Behavior; Male; Motor Activity; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Time Factors | 2019 |
Dopaminergic and serotonergic modulation of social reward appraisal in zebrafish (Danio rerio) under circumstances of motivational conflict: Towards a screening test for anti-compulsive drug action.
Topics: Animals; Apomorphine; Behavior, Animal; Citalopram; Conflict, Psychological; Disease Models, Animal; Dopamine Agonists; Feedback, Psychological; Motivation; Obsessive-Compulsive Disorder; Reward; Selective Serotonin Reuptake Inhibitors; Social Behavior; Zebrafish | 2020 |